Pediatric Seizure Management

Immediate Assessment and Intervention

The American Academy of Pediatrics recommends immediate assessment of airway, breathing, and circulation, followed by age-specific classification and seizure type identification, with benzodiazepines as first-line treatment for seizures lasting >5 minutes 1
Position the patient on their side, remove harmful objects from the environment, and protect the head from injury, as recommended by the American College of Emergency Physicians 1, 2
Never restrain the patient or place anything in the mouth during active seizure activity, as advised by the American College of Emergency Physicians 2
First-line treatment for prolonged seizures: Lorazepam 0.05-0.1 mg/kg IV (maximum 4 mg) given slowly at 2 mg/min, as recommended by the American Academy of Pediatrics 1, 2

Diagnostic Approach

Hypoxic-ischemic injury accounts for 46-65% of neonatal seizures, followed by intracranial hemorrhage and perinatal stroke (10-12%), according to the American College of Radiology 3
MRI with diffusion-weighted imaging is the most sensitive modality for detecting hypoxic-ischemic injury and cortical malformations, as recommended by the American College of Radiology 3, 4
Simple febrile seizures are defined as generalized seizures lasting <15 minutes, occurring once in 24 hours, in febrile children (temperature ≥100.4°F/38°C) without intracranial infection, according to the American Academy of Pediatrics 5, 2
Routine neuroimaging is NOT indicated for simple febrile seizures, as recommended by the American College of Radiology and the American Academy of Pediatrics 4, 1, 2

Long-Term Management

Monotherapy is the preferred initial approach for epilepsy management, with medications such as oxcarbazepine, topiramate, or levetiracetam, as recommended by the American Academy of Neurology 1
Refer to pediatric neurology if the first antiepileptic medication fails, as advised by the American Academy of Neurology 1
Regular neurological assessment, EEG monitoring, and medication side effect surveillance are essential for ongoing care, as recommended by the American Academy of Neurology 1

Prognosis and Parent Education

Simple febrile seizures have excellent prognosis with no long-term adverse effects on IQ, academic performance, or neurocognitive function, according to the American Academy of Pediatrics 5, 6
Risk of developing epilepsy after simple febrile seizures is extremely low (similar to general population), and prophylactic treatment does not reduce this risk, as stated by the American Academy of Pediatrics 5, 2
Educate caregivers about the benign nature of simple febrile seizures, practical home management, and when to seek emergency care, as recommended by the American Academy of Pediatrics 2

Management of Pediatric Seizures

Simple Febrile Seizures

The American Academy of Pediatrics recommends that neither continuous nor intermittent anticonvulsant prophylaxis is used for children with simple febrile seizures, as the potential toxicities clearly outweigh the minimal risks 7, 8
Children with simple febrile seizures have a recurrence risk, with those younger than 12 months at first seizure having approximately 50% probability of recurrence, and those older than 12 months having approximately 30% probability of a second febrile seizure 8, 9
The risk of developing epilepsy after simple febrile seizures is approximately 1% (same as general population), but children with multiple simple febrile seizures, age <12 months at first seizure, and family history of epilepsy have 2.4% risk of developing epilepsy by age 25 years 8, 9
The use of valproic acid, phenobarbital, and intermittent diazepam for prophylaxis is not recommended due to their potential harmful effects, such as rare fatal hepatotoxicity, hyperactivity, and lethargy 7

Diagnostic Evaluation and Management

The harm-benefit analysis clearly favors no treatment for simple febrile seizures, and antipyretics do not prevent febrile seizures or reduce recurrence risk 7, 8

Management of Children with Febrile Seizures

Long-Term Management and Prophylaxis

The American Academy of Pediatrics recommends that continuous anticonvulsant therapy with phenobarbital or valproic acid is effective in reducing recurrence but carries unacceptable risks including rare fatal hepatotoxicity, thrombocytopenia, weight changes, gastrointestinal disturbances, and pancreatitis with valproic acid, especially in children younger than 2 years 10
Phenobarbital causes hyperactivity, irritability, lethargy, sleep disturbances, and hypersensitivity reactions 10
Intermittent diazepam prophylaxis may reduce recurrence rates but does not improve long-term outcomes and causes lethargy, drowsiness, and ataxia 10

Prognosis and Parent Education

Simple febrile seizures cause no decline in IQ, academic performance, neurocognitive function, or behavioral abnormalities, according to the American Academy of Pediatrics 11
No evidence exists that simple febrile seizures cause structural brain damage, as stated by the American Academy of Pediatrics 11
The risk of developing epilepsy by age 7 is approximately 1%, identical to the general population, as reported by the American Academy of Pediatrics 11
Even children with multiple simple febrile seizures, first seizure before 12 months, and family history of epilepsy have only 2.4% risk of developing epilepsy by age 25 years, according to the American Academy of Pediatrics 11
Children younger than 12 months at first seizure have approximately 50% probability of recurrent febrile seizures, while children older than 12 months at first seizure have approximately 30% probability of a second febrile seizure, as stated by the American Academy of Pediatrics 11
Of those who have a second febrile seizure, 50% have at least one additional recurrence, according to the American Academy of Pediatrics 11

Management of Febrile Seizures in Children

Diagnostic Considerations

Children under 12 months of age with fever and seizure should undergo lumbar puncture to rule out meningitis, as meningeal signs may be absent in up to one-third of cases, according to the British Medical Journal guidelines 12
The American Academy of Pediatrics recommends that children with simple febrile seizures do not require routine laboratory tests, neuroimaging, or EEG, but evaluation may be needed to identify the source of fever 12

Seizure Classification and Management

Simple febrile seizure criteria include generalized seizure, duration less than 15 minutes, single episode within 24 hours, temperature ≥100.4°F (38°C), and no intracranial infection, as defined by the American Academy of Pediatrics 13
Complex febrile seizure features include duration ≥15 minutes, focal neurologic findings, or recurrence within 24 hours, according to the American Academy of Pediatrics 13

Long-Term Management and Prophylaxis

The American Academy of Pediatrics recommends against continuous or intermittent anticonvulsant prophylaxis for simple febrile seizures due to the potential toxicities outweighing the minimal risks 13
Antipyretics, such as acetaminophen, should be used for the child's comfort and to prevent dehydration, but not for seizure prevention, as stated by the British Medical Journal guidelines 12

Prognosis and Parent Counseling

Simple febrile seizures have an excellent prognosis, with no decline in IQ, academic performance, neurocognitive function, or behavior, and no structural brain damage, according to the American Academy of Pediatrics 13
The risk of developing epilepsy by age 7 is approximately 1%, identical to the general population, as reported by the American Academy of Pediatrics 13

Follow-Up and Referral

Neurological consultation should be requested if there are prolonged febrile seizures, repetitive focal febrile seizures, or abnormal neurological exam or development, according to the American Academy of Pediatrics 13
Routine follow-up with the primary care physician is recommended, including verbal counseling and supplementary written materials about febrile seizure management, as suggested by the British Medical Journal guidelines 12

Management of Febrile Seizures

Diagnosis and Investigation

The British Medical Association and American Academy of Pediatrics explicitly list electroencephalography as an inappropriate investigation that should not be performed on more than a small minority of patients with simple febrile seizures 14, 15, 16, 17

Pediatric Seizure Management

Introduction to Seizure Treatment

High seizure burden in children has been associated with poor neurological outcomes, making prompt treatment essential, according to the American Heart Association 18, 19

Special Considerations

The American Academy of Pediatrics recommends that patients with known epilepsy may have rescue medications prescribed, such as rectal diazepam or buccal midazolam, although the treatment algorithm remains the same regardless of seizure history, with benzodiazepines as first-line for any seizure lasting >5 minutes 18, 19

Discontinuation of Phenobarbital in Simple Febrile Seizures

Rationale for Discontinuation

The American Academy of Pediatrics recommends against continuous anticonvulsant therapy for children with simple febrile seizures, due to the potential toxicities outweighing the minimal risks, based on evidence quality B from randomized controlled trials 20, 21
Phenobarbital is effective in reducing recurrence rates, but this benefit does not justify the risks in simple febrile seizures, with a reduction from 25 per 100 subjects per year to 5 per 100 subjects per year 20, 21
The American Academy of Pediatrics provides a clear recommendation against both continuous and intermittent anticonvulsant therapy for children with one or more simple febrile seizures, based on aggregate evidence quality B 20, 21

Significant Risks of Phenobarbital

Behavioral adverse effects, including hyperactivity, irritability, lethargy, sleep disturbances, and hypersensitivity reactions, occur in 20-40% of patients taking phenobarbital 20, 21, 22
Cognitive impairment, with a mean IQ reduction of 7 points during treatment, and effects persisting 5.2 points lower even 6 months after discontinuation, is a significant risk of phenobarbital therapy 22

Clinical Approach to Discontinuation

The American Academy of Pediatrics recommends tapering and discontinuing phenobarbital as it was inappropriately initiated for a simple febrile seizure, providing no benefit in preventing epilepsy development and not improving long-term outcomes 20, 21
Recurrent simple febrile seizures cause no harm and do not warrant prophylactic treatment, according to the American Academy of Pediatrics 20, 21

Epilepsy and Brain Abnormalities in Children

Introduction to Epilepsy and Febrile Seizures

The American Academy of Pediatrics states that simple febrile seizures do not cause structural brain damage, with no evidence currently available to support this claim 23
Pre-existing neurological abnormalities predict epilepsy development, not the other way around, with children who had neurological abnormalities before their first seizure showing learning differences 23
The increased risk of epilepsy in children with febrile seizures is most likely due to genetic predisposition, with a risk of 2.4% by age 25 in high-risk groups 23

Cognitive and Neurological Outcomes

Neither decline in IQ, academic performance, neurocognitive attention, nor behavioral abnormalities have been shown to be a consequence of recurrent simple febrile seizures 23
A study of 431 children with febrile seizures showed no significant difference in learning compared with sibling controls 23
A separate study of 303 children with febrile seizures found no difference in learning except in those who had neurological abnormalities before their first seizure 23

Clinical Implications

The brain abnormalities detected in a child with a history of febrile seizure at age 1 who was not treated for 10 years were almost certainly present before or independent of the seizure history 23
If true epilepsy developed after the initial febrile seizure, the 10-year delay in treatment did not cause the brain abnormalities, with risk factors for developing epilepsy including neurodevelopmental abnormality, complex features, developmental delay, and genetic factors 23

Febrile Seizure Diagnosis and Management

Classification and Diagnostic Evaluation

Complex febrile seizures have one or more of the following features: duration ≥15 minutes, focal neurologic findings, or recurrence within 24 hours, according to the American College of Radiology 24
Neuroimaging is generally NOT indicated for complex febrile seizures unless specific concerning features are present, such as postictal focal neurological deficits, febrile status epilepticus, or underlying pathology, as recommended by the American College of Radiology 24
Analysis of 161 children with complex febrile seizures showed head CT revealed no findings requiring intervention, and even when imaging abnormalities are detected, these findings do not alter clinical management, according to the American College of Radiology 24

Diagnostic Evaluation and Management

The American Academy of Pediatrics explicitly recommends AGAINST both continuous and intermittent anticonvulsant prophylaxis for children with simple febrile seizures, based on high-quality evidence from randomized controlled trials 24
No neuroimaging (CT or MRI) is required for simple febrile seizures, unless specific concerning features are present, as recommended by the American College of Radiology 24

Management of Febrile Seizures in Children

Medication Guidance

The American Academy of Pediatrics recommends against prescribing continuous or intermittent anticonvulsant prophylaxis for children with simple febrile seizures, due to the potential toxicities outweighing the minimal risks 25
Valproic acid is associated with rare fatal hepatotoxicity, thrombocytopenia, weight changes, gastrointestinal disturbances, and pancreatitis in children with febrile seizures 25
Phenobarbital is linked to behavioral adverse effects in 20-40% of patients, including hyperactivity, irritability, lethargy, and sleep disturbances, as well as a mean IQ reduction of 7 points during treatment 25
Intermittent diazepam may cause lethargy, drowsiness, ataxia, and may mask evolving CNS infection 25
Carbamazepine and phenytoin are ineffective in preventing febrile seizures, with studies showing 47% recurrence with carbamazepine versus 10% with phenobarbital, and phenytoin showing no benefit even at therapeutic levels 25

Antipyretic Use

Antipyretics, such as acetaminophen and ibuprofen, do not prevent febrile seizures or reduce recurrence risk, and should only be used for the child's comfort and to prevent dehydration 25

Management of Febrile Status Epilepticus in Children – Evidence‑Based Recommendations

Immediate Stabilization and First‑Line Treatment

Assess airway, breathing, and circulation, provide high‑flow oxygen, check glucose, and give lorazepam 0.1 mg/kg IV (maximum 2 mg) as the first‑line drug; repeat after at least 1 minute if seizures continue, with a maximum of two doses. 26, 27
Transfer the child promptly to a pediatric intensive‑care unit for management of convulsive status epilepticus. 26, 27

Second‑Line Treatment (Benzodiazepine‑Refractory Seizures)

If seizures persist after the benzodiazepine dose(s), administer levetiracetam 40 mg/kg IV bolus (maximum 2,500 mg) together with ongoing maintenance dosing. 26, 27
Levetiracetam should be given concurrently with the benzodiazepine protocol rather than sequentially. 26, 27

Third‑Line Treatment (Refractory Seizures)

For seizures that remain uncontrolled after benzodiazepines and levetiracetam, add phenobarbital IV loading dose of 10–20 mg/kg (maximum 1,000 mg). 26, 27
Initiate continuous electroencephalographic monitoring when seizures are refractory to the above agents. 26, 27

Maintenance Therapy After Seizure Termination

Continue lorazepam 0.05 mg/kg IV (maximum 1 mg) every 8 hours for three doses to provide short‑term maintenance. 26, 27
Provide levetiracetam 30 mg/kg IV every 12 hours, or increase the prophylactic dose by 10 mg/kg to a total of 20 mg/kg IV every 12 hours (maximum 1,500 mg). 26, 27
If phenobarbital was used, give phenobarbital 1–3 mg/kg IV every 12 hours as maintenance. 26, 27

Prophylactic Anticonvulsant Use in Simple Febrile Seizures

Guideline Recommendation

The American Academy of Pediatrics recommends against any continuous or intermittent anticonvulsant prophylaxis—including clobazam—for children who experience simple febrile seizures, because the potential toxicities outweigh the minimal benefits; this recommendation is based on evidence quality B from randomized controlled trials. 28

Lack of Benefit of Prophylaxis

In children with simple febrile seizures, no long‑term adverse outcomes have been demonstrated (e.g., no decline in intelligence, academic performance, neurocognitive function, behavior, or structural brain injury). 28
Anticonvulsant prophylaxis does not prevent the development of epilepsy; no medication has shown efficacy in averting future afebrile seizures, which are thought to arise from genetic predisposition rather than the febrile seizures themselves. 28

Preferred Management Strategy

The recommended management for simple febrile seizures is parent education and reassurance rather than medication, emphasizing the benign nature of the condition and excellent prognosis. 28

Contraindicated Medications and Risk Profile

Clobazam, diazepam, phenobarbital, valproic acid, and all other anticonvulsants should not be prescribed for prophylaxis of simple febrile seizures. 28
High‑quality evidence demonstrates that the adverse effects of these drugs (sedation, drowsiness, ataxia, behavioral changes, and rare serious adverse events) outweigh any potential benefit in this benign condition. 28

Distinguishing Febrile Seizures from Absence Seizures

Definition and Clinical Features

In children aged 6 months to 5 years, a febrile seizure is defined as a generalized tonic‑clonic seizure that occurs only in the presence of fever (≥38 °C) and is not associated with central nervous system infection; it does not present with the brief staring spells characteristic of absence seizures. 29
Simple febrile seizures typically last from a few seconds up to 15 minutes, are generalized tonic‑clonic in nature, and are followed by a post‑ictal period of drowsiness. 29
When a child exhibits staring or behavioral arrest during a febrile illness, the event should be interpreted as an afebrile seizure occurring coincidentally with fever rather than a true febrile seizure. 29

Diagnostic Recommendations

Staring episodes that occur with fever should trigger evaluation for underlying epilepsy (e.g., absence epilepsy) or for central nervous system infection, rather than being dismissed as simple febrile seizures. 29
Electroencephalography is recommended when the clinical picture suggests an absence‑type seizure (e.g., brief staring without post‑ictal confusion) to identify the typical 2.5–4 Hz spike‑wave pattern. 29

Imaging and Ancillary Testing

Routine neuroimaging or EEG is not indicated for uncomplicated simple febrile seizures. These studies become appropriate only when the presentation raises concern for afebrile seizure types such as absence epilepsy or suggests possible intracranial pathology. 29
In infants younger than 12 months who present with fever and a seizure, clinicians should consider lumbar puncture because meningeal signs may be absent in up to one‑third of meningitis cases. 29
The American College of Radiology recommends reserving imaging for cases where atypical features (e.g., focal neurologic deficits, prolonged seizures, or suspicion of structural lesions) are present, aligning with the above guidance. 29